Signalling pathways as target for anticancer drug development

This publication has 239 references indexed in Scilit:

• Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progression
  Cell, 1993
• Stimulation of Inositol Phosphate Production and GTPase Activity by Compound 48/80 in Rat Peritoneal Mast Cells
  Biochemical and Biophysical Research Communications, 1993
• SH2 domains recognize specific phosphopeptide sequences
  Published by Elsevier ,1993
• Human therapeutics based on triple helix technology
  Trends in Biotechnology, 1992
• Approaches to proto-oncogene and tumour suppressor gene identification
  European Journal Of Cancer, 1992
• Inhibition of tyrosine protein kinases by the antineoplastic agent adriamycin
  Biochemical and Biophysical Research Communications, 1989
• Permanent conversion of mouse and human cells transformed by activatedras orraf genes to apparently normal cells by treatment with the antibiotic azatyrosine
  Molecular Carcinogenesis, 1989
• Activation of phosphatidylinositol-4-phosphate kinase in rat liver plasma membranes by polyamines
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1987
• Compound 48/80 is a potent inhibitor of phospholipase C and a dual modulator of phospholipase A2 from human platelet
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1987
• Aspirin inhibits phospholipase C
  Biochemical and Biophysical Research Communications, 1986